Investing In The Engine: Why IP Licensing May Be Best Approach For Start-Ups
Intellectual property infringement – whether intentional or accidental – is becoming a growing threat for start-ups. Medtech Insight spoke to Robert Cote, CEO of COTE Capital, an IP-based investment firm, about how medtechs can both protect their IP and actualize its value.
You may also be interested in...
AstraZeneca And Huma On Digital’s Value For Pharma
Digital tools have long been of interest to pharma for their potential to transform many aspects of drug development, leading to many collaborations between pharma and medtech firms. Here, two companies that have been working together to develop a series of software-based tools for monitoring patients – AstraZeneca and Huma – discuss the value of these partnerships and their potential challenges.
Podcast: OxSonics Hopes To Use Ultrasound To Enhance Drug Efficacy – Without Reformulation
In this one-off podcast, reporter Barnaby Pickering speaks Jérôme Marzinski and Dr Christian Coviello, the CEO and CTO, respectively, of OxSonics, a UK-based start-up which is working on an ultrasound-based technology that has been designed to enhance the potency of oncological drugs.
Speaking To AstraZeneca And Huma About Digital’s Value For Pharma
AstraZeneca has been working with Huma to develop a series of software-based tools for monitoring patients. Medtech Insight spoke to both companies about the value of these partnerships and the potential challenges.